Bionano Genomics, Inc. BNGO
1.10 USD 0.00 (+0.00%)
At closeNov 12, 2026, 8:14 AM EST
1.13 +0.03 +2.73%
Pre-market · Nov 12, 8:14 AM ET
1.09 Day range 1.30
1.00 52-week range 2.23
- YTD
- -28.10%
- 1 year
- -32.10%
News
defenseworld.net Comparing Codexis (NASDAQ:CDXS) and Bionano Genomics (NASDAQ:BNGO) Bionano Genomics (NASDAQ: BNGO - Get Free Report) and Codexis (NASDAQ: CDXS - Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two…
seekingalpha.com Bionano Genomics, Inc. (BNGO) Q3 2026 Earnings Call Transcript Bionano Genomics, Inc. (BNGO) Q3 2026 Earnings Call Transcript
benzinga.com Bionano Genomics Q3 2026 Earnings Call Transcript Bionano Genomics (NASDAQ:BNGO) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide…
benzinga.com Bionano Genomics Q3 EPS $(0.54) Misses $(0.51) Estimate, Sales $8.276M Miss $8.443M Estimate Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.51) by 8 percent. This is a 66.04 percent increase over losses of…
benzinga.com Bionano Genomics Affirms FY2026 Sales Guidance of $31.000M-$33.000M vs $32.474M Est Bionano Genomics (NASDAQ:BNGO) affirms FY2026 sales outlook from $31.000 million-$33.000 million to $31.000 million-$33.000 million vs $32.474 million estimate.- benzinga.com Bionano Genomics Q3 Sales $8.276M Miss $8.443M Estimate Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $8.276 million which missed the analyst consensus estimate of $8.443 million by 1.98 percent. This is a 12.34 percent increase over sales of…
globenewswire.com Bionano Reports Third Quarter 2026 Results and Provides a Business Update Conference call today, November 10, 2026, at 4:30 PM ET SAN DIEGO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended…
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Tempest Therapeutics (NASDAQ:TPST) stock increased by 41.6% to $1.07 during Tuesday's after-market session. The company's market cap stands at $12.9 million. Jupiter Neurosciences…
benzinga.com Bionano Genomics Stock Surges Tuesday: What's Going On? Bionano Genomics is surging Tuesday as investors weigh its growth strategy and favorable milestones for its genome mapping technology.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers PDS Biotechnology (NASDAQ:PDSB) shares rose 63.7% to $0.65 during Tuesday's regular session. The market value of their outstanding shares is at $22.3 million. DataMEDS AI (NASDAQ:MEDS) shares…- benzinga.com Bionano Genomics Highlights Three New Independently Authored, Peer-Reviewed Publications Showing Clinical Utility Of OGM In High-Risk Hematologic Malignancies Bionano Genomics, Inc. (NASDAQ:BNGO) today highlighted three new independently authored, peer-reviewed publications demonstrating the clinical utility of OGM in high-risk hematologic malignancies —…
benzinga.com Bionano Genomics Subsidiary Says MolDX Issues Proposed LCD For Genome-Wide Molecular Methodologies For Detection Of Copy Number Alterations And Structural Variants In Hematologic Neoplasms Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (NASDAQ:BNGO) that offers CLIA-certified laboratory developed test (LDTs), today announced that MolDX, a program that…- benzinga.com Bionano Genomics Raises FY2026 Sales Guidance from $30.000M-$33.000M to $31.000M-$33.000M vs $32.137M Est Bionano Genomics (NASDAQ:BNGO) raises FY2026 sales outlook from $30.000 million-$33.000 million to $31.000 million-$33.000 million vs $32.137 million estimate.
benzinga.com Transcript: Bionano Genomics Q1 2026 Earnings Conference Call - benzinga.com Bionano Genomics Q1 EPS $(0.76) Beats $(0.95) Estimate, Sales $6.687M Beat $6.567M Estimate Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.76) per share which beat the analyst consensus estimate of $(0.95) by 20 percent. This is a 33.91 percent increase over losses of…
- benzinga.com Bionano Genomics Affirms FY2026 Sales Guidance of $30.000M-$33.000M vs $32.137M Est Bionano Genomics (NASDAQ:BNGO) affirms FY2026 sales outlook from $30.000 million-$33.000 million to $30.000 million-$33.000 million vs $32.137 million estimate.
benzinga.com Earnings Scheduled For May 13, 2026 
benzinga.com Bionano Genomics Files Shelf Registration To Offer Up To $400M In Common Stock, Preferred Stock, Debt, Warrants, And Units $400,000,000Common StockPreferred StockDebt SecuritiesWarrantsUnitsFrom time to time, we may offer and sell up to an aggregate amount of $400,000,000 of any combination of the securities described in…- benzinga.com Bionano Genomics Appoints Chairman Al Luderer Interim President, CEO, Effective Immediately Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Al Luderer, Ph.D., chairman of Bionano's Board of Directors, has been appointed interim president and chief executive officer, effective May…
benzinga.com HC Wainwright & Co. Maintains Buy on Bionano Genomics, Lowers Price Target to $6 HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and lowers the price target from $7 to $6.
benzinga.com Bionano Genomics Stock Soars As Efficiency Gains Meet Growth Story Bionano Genomics stock soared on Monday as investors anticipated the company's Q4 earnings report.- benzinga.com Earnings Scheduled For March 23, 2026
benzinga.com Nasdaq Tumbles 2% Amid Rate-Hike Fears: Fear & Greed Index Remains In 'Extreme Fear' Zone The CNN Fear & Greed Index increased due to ongoing conflicts. U.S. stocks closed lower, with Nasdaq down 2%, while energy and financial sectors gained.
benzinga.com United Airlines, AGI And 3 Stocks To Watch Heading Into Monday US stock futures down, Caledonia Mining, United Airlines & Agi to report earnings, Cheetah Net & BioNano Genomics to release results.
benzinga.com Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call Bionano Genomics, Inc. (BNGO) will release Q4 earnings on March 23. Analysts expect $1.40 loss per share on $7.85M revenue. Stock closed at $1.12.- benzinga.com Bionano Announces Two-Fold Increase in OGM Studies Presented At Annual Clinical Genetics Meeting Bionano Genomics participated in the 2026 American College of Medical Genetics and Genomics Annual Meeting (ACMG), held March 14–18 in Baltimore, Maryland. Twelve studies, representing a two-fold…
benzinga.com Bionano Genomics Publishes Study On Application Of Optical Genome Mapping To Trace Genomic Alterations Introduced By Different Gene Editing Technologies Bionano Genomics, Inc. (Nasdaq: BNGO) announced a peer-reviewed study published in Molecular Therapy - Methods & Clinical Development, describing the application of optical genome mapping (OGM) to…
benzinga.com Bionano Laboratories Gains 47% CMS Reimbursement Increase For OGM Blood-Cancer Test Code 81195 In 2026 Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (NASDAQ:BNGO) offering CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), announced…
benzinga.com Baidu To Rally More Than 69%? Here Are 10 Top Analyst Forecasts For Monday - benzinga.com HC Wainwright & Co. Maintains Buy on Bionano Genomics, Lowers Price Target to $7 HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and lowers the price target from $11 to $7.
- benzinga.com Bionano Genomics Affirms FY2025 Sales Guidance of $26.000M-$30.000M vs $28.136M Est Bionano Genomics (NASDAQ:BNGO) affirms FY2025 sales outlook from $26.000 million-$30.000 million to $26.000 million-$30.000 million vs $28.136 million estimate.
- benzinga.com Bionano Genomics Q3 EPS $(1.59) Beats $(1.91) Estimate, Sales $7.367M Beat $6.871M Estimate Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(1.59) per share which beat the analyst consensus estimate of $(1.91) by 16.75 percent. This is a 94.86 percent increase over losses of…
- benzinga.com Bionano Genomics Q3 Sales $7.367M Beat $6.871M Estimate Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $7.367 million which beat the analyst consensus estimate of $6.871 million by 7.22 percent. This is a 21.31 percent increase over sales of…
- benzinga.com Earnings Scheduled For November 13, 2025
- benzinga.com Bionano Genomics Publishes Study Demonstrating That Optical Genome Mapping Can Overcome Key Limitations Of Targeted RNA-Sequencing Panels In Detecting Therapeutically Relevant Gene Rearrangements In Acute Leukemia Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study in Cancers from The University of Texas MD Anderson Cancer Center showing how optical genome mapping (OGM) can address…
- benzinga.com Bionano Genomics Highlighted Expanding Role Of Optical Genome Mapping In Genetic Disease Research At ASHG Conference Bionano Genomics, Inc. (NASDAQ:BNGO) participated in The American Society of Human Genetics (ASHG) conference from October 14–18, 2025 in Boston. The event highlighted the potential for an expanding…
benzinga.com Crude Oil Rises Over 2%; Bionano Genomics Shares Plunge - benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com Why BioNano Genomics (BNGO) Stock Is Getting Hammered Tuesday BioNano Genomics shares are trading sharply lower in Tuesday's session. The company announced the pricing of a $10 million public offering.
benzinga.com Dow Falls Over 100 Points; US Retail Sales Top Estimates 
benzinga.com Bionano Genomics Prices $10M Public Offering Of 5M Shares And Series Warrants At A Combined Price Of $2.00; Could Potentially Earn $20M From Warrant Exercises Bionano Genomics, Inc. (NASDAQ:BNGO) ("Bionano" or the "Company") today announced the pricing of a public offering of an aggregate of 5,000,000 shares of the Company's common stock (or common stock…
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session - benzinga.com Bionano Genomics Selected For Sole Source Contract By NIH For Optical Genome Mapping Reagents And Instruments; No Contract Value Disclosed https://sam.gov/opp/7a19a6e8954c4de1a128b841e2018400/view DescriptionThis is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be…
- benzinga.com Earnings Scheduled For August 14, 2025
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com Earnings Scheduled For May 14, 2025 - benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com Earnings Scheduled For March 31, 2025
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com Earnings Scheduled For November 13, 2024